UK consensus on normal tissue dose constraints for stereotactic radiotherapy

UK consensus on normal tissue dose constraints for stereotactic radiotherapy

Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...

Bibliografski detalji
Glavni autori:	Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2017

Slični predmeti

UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
od: Hanna, G, i dr.
Izdano: (2016)

Stereotactic body radiotherapy for liver metastases.
od: Aitken, K, i dr.
Izdano: (2015)

Stereotactic body radiotherapy for oligometastases.
od: Tree, A, i dr.
Izdano: (2013)

A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
od: Khoo, V, i dr.
Izdano: (2018)

CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
od: Khoo, V, i dr.
Izdano: (2017)

CORE: A randomised trial of COventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases
od: Khoo, V, i dr.
Izdano: (2017)

Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?
od: Aitken, K, i dr.
Izdano: (2015)

Multi-center evaluation of dose conformity in stereotactic body radiotherapy
od: Jonny Lee, i dr.
Izdano: (2019-07-01)

Four-dimensional computed tomography contouring variability in stereotactic body radiotherapy of non-resectable biliary tract cancer
od: Robinson, M, i dr.
Izdano: (2017)

Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.
od: Murray, L, i dr.
Izdano: (2017)

Stereotactic Body Radiotherapy for Prostate Cancer
od: Neil R. Parikh M.D., i dr.
Izdano: (2020-06-01)

Stereotactic Radiotherapy for Renal Denervation
od: Mahfoud, Felix, i dr.
Izdano: (2020)

Stereotactic Radiotherapy in Uveal Melanoma
od: Ela Delikgöz Soykut, i dr.
Izdano: (2014-09-01)

Stereotactic hypofractive radiotherapy in the treatment of patients with lung cancer
od: T. N. Borisova, i dr.
Izdano: (2020-12-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
od: Atsuto Katano MD, PhD, i dr.
Izdano: (2024-02-01)

Editorial: Stereotactic body radiotherapy for lung cancer
od: An Liu, i dr.
Izdano: (2023-04-01)

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
od: Reem Alomran, i dr.
Izdano: (2021-03-01)

Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy
od: Rajesh Ashok Kinhikar, i dr.
Izdano: (2015-01-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
od: N V. N. Madhusudhana Sresty, i dr.
Izdano: (2021-01-01)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors
od: Michael Hanzly, i dr.
Izdano: (2014-09-01)

Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
od: Tse, R, i dr.
Izdano: (2008)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
od: Steven Eric Finkelstein, i dr.
Izdano: (2011-01-01)

Stereotactic radiotherapy: An educational narrative review
od: Agha Muhammad Hammad Khan, i dr.
Izdano: (2024-03-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
od: Bin Qiu, i dr.
Izdano: (2020-08-01)

Advantages of mini-multileaf in stereotactic radiotherapy
od: Kurup PGG, i dr.
Izdano: (2007-01-01)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
od: Harish N. Vasudevan, i dr.
Izdano: (2017-06-01)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
od: Holyoake, D, i dr.
Izdano: (2016)

A framework for exactrac dynamic commissioning for stereotactic radiosurgery and stereotactic ablative radiotherapy
od: Ben Perrett, i dr.
Izdano: (2022-01-01)

Predictors of Radiotherapy Induced Bone Injury (RIBI) after stereotactic lung radiotherapy
od: Taremi Mojgan, i dr.
Izdano: (2012-09-01)

Restricted bowel loop contouring: Improving efficiency in radiotherapy contouring for abdomino-pelvic Stereotactic Ablative Radiotherapy (SABR)
od: Eleanor Clarke, i dr.
Izdano: (2020-09-01)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
od: Luke Nicholls, i dr.
Izdano: (2020-11-01)

Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
od: Buwenge M, i dr.
Izdano: (2018-10-01)

The Utility of Spectroscopic MRI in Stereotactic Biopsy and Radiotherapy Guidance in Newly Diagnosed Glioblastoma
od: Abinand C. Rejimon, i dr.
Izdano: (2024-03-01)

Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients
od: Dazhen Jiang, i dr.
Izdano: (2024-09-01)

Repeated stereotactic radiotherapy of recurrent ventricular tachycardia
od: Jakub Cvek, i dr.
Izdano: (2023-07-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
od: Julia Malone, BSC, i dr.
Izdano: (2020-11-01)

Harmonization of dose prescription for lung stereotactic radiotherapy
od: Guillaume Beldjoudi, i dr.
Izdano: (2022-10-01)

Editorial: Stereotactic body radiotherapy for prostate cancer
od: Amar U. Kishan, i dr.
Izdano: (2022-10-01)

Non-stereotactic radiotherapy in older cancer patients
od: Silvana Parisi, i dr.
Izdano: (2022-06-01)

Stereotactic body radiotherapy in lung cancer: an update
od: Carlos Eduardo Cintra Vita Abreu, i dr.
Izdano: (2015-08-01)